Sawyer & Company, Inc United Therapeutics Corp Transaction History

Sawyer & Company, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 31, 2020	SELL	$92.74 - $125.82 $401,007 - $544,045	-4,324 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$79.39 - $115.35 $79,390 - $115,350	-1,000 Reduced 18.78%	4,324 $410,000
Q3 2019 Oct 17, 2019	SELL	$74.85 - $85.99 $25,149 - $28,892	-336 Reduced 5.94%	5,324 $425,000
Q2 2019 Jul 23, 2019	SELL	$76.06 - $120.81 $30,424 - $48,324	-400 Reduced 6.6%	5,660 $442,000
Q4 2018 Jan 25, 2019	SELL	$101.4 - $128.73 $15,210 - $19,309	-150 Reduced 2.42%	6,060 $660,000
Q4 2017 Jan 11, 2018	BUY	$118.58 - $151.28 $736,381 - $939,448	6,210	6,210 $919,000

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Sawyer & Company, Inc, based on Form 13F filings with the SEC.

Stay updated on Sawyer & Company, Inc with notifications on news.